Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001172661-25-003448
Filing Date
2025-08-14
Accepted
2025-08-14 15:48:09
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 11979
  Complete submission text file 0001172661-25-003448.txt   13758
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Subject) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: SCHEDULE 13G | Act: 34 | File No.: 005-40503 | Film No.: 251218168
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 1177 AVE. OF THE AMERICAS 46TH FLOOR NEW YORK NY 10036
Business Address 1177 AVE. OF THE AMERICAS 46TH FLOOR NEW YORK NY 10036 212-626-1421
Gates Capital Management, Inc. (Filed by) CIK: 0001312908 (see all company filings)

EIN.: 133886865 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G